Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Windtree Therapeutics Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 5 | 5 | 0 |
| Shares | 45.3K | 17.0K | −28.3K (−62.5%) |
| Value | $57.0K | $8.75K | −$48.3K (−84.7%) |
New holders (1)
Institutions that held Windtree Therapeutics Inc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 14,599 | $7.53K | 0.00% |
Sold out (1)
Institutions that held Windtree Therapeutics Inc at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Morgan Stanley | 15,000 | $18.9K |